Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients
Al B. Benson, Olufunmilayo I. Olopade, Mark J. Ratain, Alfred Rademaker, Sohrab Mobarhan, Lisa Stucky-Marshall, Suzanne French, M. Eileen Dolan
Dive into the research topics of 'Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients'. Together they form a unique fingerprint.